* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 4000 tests per day.

Total Reported: 587,000+

Turnaround

0.5 Days

Please email our courier service department for fast and reliable specimen pickup and transfer.

NEWS & RESOURCES

COVID-19 VIRUS IN OUR SIGHTS

Steven I. Marlowe MD FACP FIDSA Medical Director, Molecular Diagnostics. Dear Family and Friends — We’re learning more and more about this epidemic as it progresses,

Read More »